Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Hepatitis C candidate EDP-494 shows promise in early clinical trial

Nov. 25, 2016

Mutabilis discloses beta-lactamase inhibitors

Nov. 25, 2016

Arsanis initiates phase II trial of ASN-100 to prevent S. aureus pneumonia

Nov. 24, 2016

University of Colorado patent reveals beta-lactam antibiotic sensitizers

Nov. 23, 2016

Gates Foundation grant supports NovoBiotic's work on orally active analogues of teixobactin for TB

Nov. 23, 2016

Enamine and Pcovery extend collaboration

Nov. 23, 2016

ENDURANCE-4 trial shows efficacy of glecaprevir/pibrentasvir in HCV genotypes 4-6

Nov. 23, 2016

Oral, ultra-long-acting form of ivermectin achieves sustained therapeutic serum drug concentrations

Nov. 23, 2016

Phase I clinical testing of the hookworm vaccine NA-APR-1

Nov. 22, 2016

Novel Zika virus vaccine based on the Zika E glycoprotein

Nov. 22, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...